Sirrus, Inc., a Cincinnati, OH-based developer of monomers and derivatives which allow reduction or elimination of energy consumption and improved product performance in manufacturing, decorating and assembly, closed $6.5m in Series B financing.
The round was co-led by Braemar Energy Ventures and GM Ventures with participation from existing investors Arsenal Venture Partners and Mitsui Global Investments.
The company intends to use the funds to complete process development at pilot scale, design modular facilities and support commercialization of its novel platform of reactive monomers, which is marketed under the brand names Chemilian™ and Forza™.
Founded in 2009 and led by Jeff Uhrig, CEO, Sirrus was formed to commercialize monomers and derivatives that allow cycle time reduction, energy savings, and new material selection in a broad range of customer and consumer applications, including automotive, building and construction, electronics, packaging and hygiene.
The company was previously known as Bioformix.